BMY
BRISTOL MYERS SQUIBB CO
NYSE · Healthcare · Drug Manufacturers - General · US
$63.06
+0.35%Forward multiples
Based on analyst estimates
- P/E forward
- 9.80x
- P/E 2026E
- 9.02x
- P/E 2027E
- 9.56x
- P/E 2028E
- 11.13x
- P/S forward
- 2.65x
Trailing multiples
Trailing twelve months
- P/E TTM
- 13.89x
- PEG TTM
- 0.33x
- Price / book
- 5.77x
- Price / sales
- 2.62x
- Price / cash flow
- 10.08x
Enterprise value
- Enterprise value
- $160.9B
- EV / sales
- 3.27x
- EV / EBITDA
- 9.65x
- EV / EBIT
- 11.57x
- Market cap
- $128.8B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026